Learn more about Elias Cancer Immunotherapy (ECI), a newly USDA-approved treatment for dogs with osteosarcoma. It explains how ECI works, its benefits, success rates, costs, and availability for families seeking new options in canine cancer care.

Dr. Jeffrey Bryan of the University of Missouri explains how the Elias Cancer Immunotherapy works, what the response rates look like, and the types of canine cancers it may treat. He also addresses eligibility, access, and potential side effects.

A new Ardent Animal Health trial is enrolling dogs with osteosarcoma to test a combination immunotherapy using a tumor-derived vaccine and a novel checkpoint inhibitor.

A New Promising Combination Immunotherapy Trial: Autologous Cancer Vaccine with Immune Checkpoint Inhibitor (K9-ACV + ICI)

EGFR vaccine helped Dennis overcome osteosarcoma without losing his leg.

List of new immunotherapy treatments for dogs with osteosarcoma. Immunotherapy treatments may give dogs a chance for longer remission and survival, compared to standard therapies alone (e.g. surgery plus chemotherapy)

Three dogs had osteosarcoma that had metastasized to their lungs. But thanks to immunotherapy, they became cancer-free.

This webinar shared surprising findings from 2024, including hemangiosarcoma treatments, osteosarcoma treatment without surgery, and more.

Immunocidin may be a gentler alternative to chemotherapy, according to Max's mom.